BPA increases the number of adipocytes by regulating the expression of the FABP4, CD36, and PCSK1 genes; decreases the release of adiponectin and other adipokines; and disrupts adipocyte metabolism, thus increasing the risk of developing obesity. The gene discussed is CD36; the disease is obesity due to melanocortin 4 receptor deficiency.